GlassScriptPhysician profile
Leslie P Lawley
NPI 1700905932
$10,731.06
in general payments reported to CMS, 2019-2025
6 companies · $3,740 in 2025
The $3,740 reported for 2025 was more than what 87% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,325 · 2023: $15.96 · 2024: $5,650 · 2025: $3,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Honoraria: $4,040 · Education: $66.96 · Food and Beverage: $49.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Honoraria | $4,040.00 |
| Education | $66.96 |
| Food and Beverage | $49.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,250.00 | 2024 | |
| Chiesi USA, INC. | $3,689.08 | 2025 | Filsuvez |
| Amryt Pharma Holdings LTD | $1,300.00 | 2022 | |
| Nobelpharma America, LLC | $400.00 | 2024 | |
| Krystal Biotech INC | $66.96 | 2023-2025 | Vyjuvek |
| Incyte Corporation | $25.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Lawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.